The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
- 20 June 1997
- journal article
- Published by Elsevier
- Vol. 221 (2-3) , 157-160
- https://doi.org/10.1016/s0304-3940(96)13308-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2Life Sciences, 1995
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- Neuropathic pain sensations are differentially sensitive to dextrorphanNeuroReport, 1994
- Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nervePain, 1994
- Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primatePAIN®, 1994
- Conformationally restrained analogs of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptorJournal of Medicinal Chemistry, 1992
- Further studies on the antinociceptive effects ofΔ acidInflammation Research, 1990
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988
- Changes in body temperature after administration of antipyretics, LSD, Δ9-THC and related agents: IINeuroscience & Biobehavioral Reviews, 1987